Sciformix Corp., a Westborough data-management company serving life sciences companies, has completed a $3.3 million round of financing led by Flybridge Capital Partners of Boston.
Sciformix said it will use the money to expand its sales and marketing and its global operations.
As part of the deal, Flybridge general partner Chip Hazard joined the company’s board of directors.
Drug safety and clinical data management markets are currently estimated at $820 million and projected to grow to $1.2 billion, Sciformix CEO Dinesh Thakur said in a statement.
Flybridge is an early-stage venture capital firm with $560 million under management. It focuses on consumer, healthcare and information technology markets.
